MNI: US TSY: LOWERS Q3 BORROWING ESTIMATE BY $106B TO $740B

MNI BRIEF: US Treasury Lowers Q3 Borrowing Estimate By $106B

MNI BRIEF: New Powers For UK Fiscal Body As Spending Overshot

MNI China Daily Summary: Monday, July 29

MNI: PBOC Net Injects CNY243.37 Bln via OMO Monday

MNI: PBOC Sets Yuan Parity Higher At 7.1316 Mon; -1.56% Y/Y

MNI: UK JUL BRC SHOP PRICES -0.1% M/M, +0.2% Y/Y

BRC-NielsenIQ: Shop Price Inflation Remains Lowest Since Oct'21

EZ/UK T-Bill Calendar: Belgium Nov 7, 2024 Short TC Due Tuesday

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Oxford Uni: Risk Of Rare Clot 8x More From Contracting COVID Than AZ Jab

GLOBAL

Oxford University scientists have released a finding from their assessment of COVID-19 vaccines relating to a rare type of blood clot.

  • The findings state that the risk of the blood clot is 100x higher following a COVID-19 infection than would be expected normally.
  • The risk of developing the clot is 8x higher following a COVID-19 infection than the following the first dose of the Oxford/AstraZeneca vaccine.
  • The risk of developing the clot is 10x higher from a COVID-19 infection than from the first dose of mRNA vaccines such as those developed by Moderna and Pfizer/BioNTech.
  • Yesterday, Danish officials announced that the rollout of the AZ jab would be discontinued permanently in the country, which is expected to delay the full rollout of COVID-19 vaccines in the country by several weeks.
Homepagemarkets-real-timePolitical RiskEmerging Market NewsPolitical Risk BulletBulletMarketsFixed Income BulletsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.